Oncolytics Biotech confirms the FDA granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of primary peritoneal cancers (ONCY) :
In 2015 Orions will be a Happy Trading Board.. stop by and make money wiht us...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.